~~<i id='AF5B266FC5'><strike id='AF5B266FC5'><tt id='AF5B266FC5'><pre id='AF5B266FC5'></pre></tt></strike></i>~~

Home» Wikipedia» explore

explore

author：focus 2025-09-29 09:03:32 Page View：1

Illustration of a road with a chasm in the middle, indicating the end of a deal or a problem with a deal — Adobe

A deal is never really done until it’s done.

On Tuesday, two different proposed insurance plan acquisitions on different sides of the country called it quits — one of them for the second time.

California-based Medicare Advantage insurer SCAN Group has been trying to buy CareOregon, an insurer offering coverage to half a million people in Oregon’s state health plan, since January 2023. National insurer Elevance has also been trying to buy Blue Cross and Blue Shield of Louisiana since last January. The on-again, off-again purchase was paused in September 2023 because of state regulators’ concerns, but was resubmitted with a slightly different plan in December.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Ukraine and a new approach to mental health in war
Next article： Anesthesiologist group: stop taking Ozempic before surgery

knowledge

Supreme Court strikes down use of affirmative action

ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

Pumping milk in bathrooms at health conferences is common

AdobeEventhoughErinBoothwasnotthrilledabouthavingtotraveltoPhiladelphiaforaconferenceatsixweekspostp

At least 13 dead in Texas as scorching temps continue

1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

AdobeTheFoodandDrugAdministrationsaidMondaythatithasdeepreservationsaboutNurOwn,aninvestigationalALS

WSS

explore

explore

comprehensive

knowledge

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds